Allspring Global Investments’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,531
Closed -$82.2K 2920
2023
Q2
$82.2K Sell
2,531
-358,232
-99% -$13.1M ﹤0.01% 2132
2023
Q1
$14.1M Buy
360,763
+15,706
+5% +$768K 0.02% 693
2022
Q4
$18.2M Buy
345,057
+225,689
+189% +$11M 0.03% 612
2022
Q3
$5.37M Sell
119,368
-20,109
-14% -$865K 0.01% 960
2022
Q2
$5.08M Buy
139,477
+6,333
+5% +$230K 0.01% 982
2022
Q1
$5.5M Buy
133,144
+99
+0.1% +$3.48K 0.01% 1106
2021
Q4
$5.67M Buy
+133,045
New +$6.66M 0.01% 1134

Other funds holding SILK

Allspring Global Investments's SILK Position: Q3 2023 in Review

Allspring Global Investments sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 2,531 shares — an estimated $82.2K sold.

Allspring Global Investments first reported a position in SILK in Q4 2021 and held it in 7 quarters. The position peaked at $18.2M in Q4 2022. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Allspring Global Investments reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 2,531 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $82.2K.
  • Allspring Global Investments first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Allspring Global Investments's Silk Road Medical, Inc. Common Stock position peaked at $18.2M in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.